Welcome: Guest

log in

Insight Pharma Reports

Insight Pharma Reports is the premier life science information provider. They cover key issues in drug discovery and development. Their reports are used by leading pharmaceutical, biotech, diagnostic, and other life science companies to keep abreast of the latest developments in pharmaceutical R&D and their potential applications and business impacts. Written by experts in consulting and industry and supported by hundreds of hours of primary and secondary research.

Title Date Price
Approaches to Reducing Phase II Attrition
May 2009 £2,255
Medicinal Chemistry for Drug Discovery
Significance of Recent Trends
Mar 2009 £2,255
Direct-To-Consumer Genetic Testing
Business Prospects in the United States
Mar 2009 £2,255
Protease Inhibitors
Innovation Drives Drug Pipeline
Feb 2009 £2,255
Molecular Diagnostics
A Dynamic and Rapidly Broadening Market Overview
Jan 2009 £2,255
Biomedical Imaging
From Drug Target Discovery to Medical Diagnostics
Dec 2008 £2,255
Conducting Clinical Trials in Europe
An Insider's Analysis
Dec 2008 £2,255
Neurodegenerative Diseases
Next-Generation Drugs for Four Major Disorders
Dec 2008 £2,255
Stem Cells Come of Age
Nov 2008 £2,255
GPCRs: Dawn of a New Era?
Oct 2008 £2,255
Immunotherapies and Vaccines for Cancer and Infectious Diseases
Oct 2008 £2,255
Strategic Management of Resources and Portfolios
Structuring Risk to Maximize Opportunity in Pharmaceutical R&D
Aug 2008 £2,255
Antibiotic R&D
Resolving the Paradox between Unmet Medical Need and Commercial Incentive
Jul 2008 £2,255
Cancer Biomarkers
Adoption Is Driving Growth
Jul 2008 £2,255
Cardiotoxicity: Issues, Technologies, and Solutions for the Future
May 2008 £2,255
Blood-Brain Barrier
Bridging Options for Drug Discovery and Development
May 2008 £675
Systems Biology
A Disruptive Technology
May 2008 £675
Inflammatory Directions
Strategies for Six Diseases with Unmet Needs
Apr 2008 £675
MicroRNAs
Commercial Products on the Horizon
Mar 2008 £675
Epigenetics
Technologies, Applications, and the Commercial Landscape
Feb 2008 £675

Industry Events